Drug intelligence / Profile preview

anshen buxin wan

Development stage: Unknown
Lead developer: Shandong Wohua Pharmaceutical
Administration: Oral

Overview

Anshen Buxin Pill (安神补心丸) is a traditional Chinese medicine (TCM) product manufactured by Shandong Wohua Pharmaceutical. It is formulated based on traditional principles to nourish the heart and calm the nerves. The medication is indicated for the treatment of insomnia, palpitations, dizziness, and neurasthenia, particularly those arising from a deficiency in heart-blood or yin. The formula typically includes a combination of botanical and mineral ingredients such as *Salvia miltiorrhiza*, *Schisandra chinensis*, and *Concha Margaritifera*. It is administered orally as a pill and is widely available as an approved over-the-counter or prescription TCM in China.

Brand names: Anshen Buxin Pill
Other names: 安神补心丸Anshen Buxin Wan

Beyond the preview

Go deeper on anshen buxin wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on anshen buxin wan.

Explore the full profile